Common Contracts
3 similar Manufacturing and Supply Agreement contracts
MANUFACTURING AND SUPPLY AGREEMENT MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • October 28th, 2021 • New York
THIS MANUFACTURING AND SUPPLY AGREEMENT effective as of the date of the last signature below (the “Effective Date”) is made by and among Pfizer Export B.V., a company established under the laws of the Netherlands with its registered office at Rivium Westlaan 142, 2909LD Capelle aan den Ijssel, the Netherlands (hereinafter “Pfizer”) and Albania Ministry of Health and Social Protection, acting on its own behalf and on behalf of the Republic of Albania with offices at Kavaja St 25, Tirana 1001 (“MOH”), Albanian Minister of State for Reconstruction,acting on its own behalf and on behalf of the Republic of Albania with offices at Boulevard “Dëshmorët e Kombit”, Tirana 1001 (MOR) and Institute of Public Health, acting on its own behalf and on behalf of the Republic of Albania with offices at Rr. Aleksander Moisiu, nr. 80, Tirana, 1001 (“IPH”) (MOH,MORand IPH, individually and collectively referred to hereinafter as “Purchaser”). Purchaser and Pfizer may be referred to herein individually as
MANUFACTURING AND SUPPLY AGREEMENT BY AND AMONGManufacturing and Supply Agreement • August 5th, 2021 • New York
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • January 19th, 2021 • New York
THIS MANUFACTURING AND SUPPLY AGREEMENT effective as of the date of the last signature below (the “Effective Date”) is made by and among Pfizer Export B.V., a company established under the laws of the Netherlands with its registered office at Rivium Westlaan 142, 2909LD Capelle aan den Ijssel, the Netherlands (hereinafter “Pfizer”) and Albania Ministry of Health and Social Protection, acting on its own behalf and on behalf of the Republic of Albania with offices at Kavaja St 25, Tirana 1001 (“MOH”), Albanian Minister of State for Reconstruction,acting on its own behalf and on behalf of the Republic of Albania with offices at Boulevard “Dëshmorët e Kombit”, Tirana 1001 (MOR) and Institute of Public Health, acting on its own behalf and on behalf of the Republic of Albania with offices at Rr. Aleksander Moisiu, nr. 80, Tirana, 1001 (“IPH”) (MOH,MORand IPH, individually and collectively referred to hereinafter as “Purchaser”). Purchaser and Pfizer may be referred to herein individually as
